DNA replication stress and mitotic catastrophe mediate sotorasib addiction in KRASG12C-mutant cancer

被引：0
|
作者：
Chiou, Li-Wen
Chan, Chien-Hui
Jhuang, Yu-Ling
Yang, Ching-Yao
Jeng, Yung-Ming
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2848
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2848
引用
收藏
页数：2
相关论文
共 50 条
  • [31] An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations
    Strohbehn, Garth W.
    Sankar, Kamya
    Qin, Angel
    Kalemkerian, Gregory P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (14) : 1569 - 1575
  • [32] Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
    Zhang, Shannon S.
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 115 - 122
  • [33] Bcl-xL and association with apoptosis following KRASG12C inhibition in KRASG12C mutant colorectal cancer.
    Khawaja, Hajrah
    Briggs, Rebecca
    Latimer, Cheryl
    Rassel, Md A. M. B.
    Griffin, Daryl
    Hanson, Lyndsey
    Bardelli, Alberto
    Di Nicolantonio, Federica
    McDade, Simon
    Scott, Christopher
    Lambe, Shauna
    Maurya, Manisha
    Lindner, Andreas Ulrich
    Prehn, Jochen H. M.
    Sousa, Jose
    Winnington, Chris
    LaBonte, Melissa J.
    Ross, Sarah
    Van Schaeybroeck, Sandra
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] The combination of neratinib with sotorasib is synergistic in models of HER2-amplified and KRASG12C-mutated cancer
    Castel, Myra E.
    Conlon, Neil T.
    Walsh, Naomi
    Bischof, Georg F.
    Crown, John P.
    Collins, Denis M.
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Proteomic and transcriptomic subtypes of KRASG12c mutant lung cancer.
    Solanki, Hitendra Singh
    Stewart, Paul A.
    Welsh, Eric A.
    Izumi, Victoria
    Fang, Bin
    Yoder, Sean J.
    Koomen, John M.
    Haura, Eric B.
    CANCER RESEARCH, 2022, 82 (12)
  • [36] Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer
    Elkrief, Arielle
    Riccuiti, Biagio
    Alessi, Joao, V
    Fei, Teng
    Kalvin, Hannah L.
    Egger, Jacklynn, V
    Rizvi, Hira
    Thummalapalli, Rohit
    Lamberti, Guiseppe
    Plodkowski, Andrew
    Hellmann, Matthew D.
    Kris, Mark G.
    Arcila, Maria E.
    Baine, Marina K.
    Rudin, Charles M.
    Lito, Piro
    Ladanyi, Marc
    Schoenfeld, Adam J.
    Riely, Gregory J.
    Awad, Mark M.
    Arbour, Kathryn C.
    ONCOLOGIST, 2023, : 978 - 985
  • [37] Nonclinical Safety Profile of Sotorasib, a KRASG12C-Specific Covalent Inhibitor for the Treatment of KRAS p.G12C-Mutated Cancer
    Ishida, Katsu
    Werner, Jonathan A.
    Davies, Rhian
    Fan, Fan
    Thomas, Barbara
    Wahlstrom, Jan
    Lipford, James Russell
    Monticello, Thomas
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (05) : 427 - 441
  • [38] Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
    Bastian Gastl
    Kathleen Klotz-Noack
    Bertram Klinger
    Sylvia Ispasanie
    Krenoula Hani Fouad Salib
    Johannes Zuber
    Soulafa Mamlouk
    Natalie Bublitz
    Nils Blüthgen
    David Horst
    Markus Morkel
    Reinhold Schäfer
    Christine Sers
    Cell Death & Disease, 11
  • [39] Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib"
    Ernst, Sophie M.
    von der Thusen, Jan H.
    Dubbink, Hendrikus J.
    Dingemans, Anne-Marie C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (08) : e29 - e30
  • [40] Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
    Gastl, Bastian
    Klotz-Noack, Kathleen
    Klinger, Bertram
    Ispasanie, Sylvia
    Salib, Krenoula Hani Fouad
    Zuber, Johannes
    Mamlouk, Soulafa
    Bublitz, Natalie
    Bluethgen, Nils
    Horst, David
    Morkel, Markus
    Schaefer, Reinhold
    Sers, Christine
    CELL DEATH & DISEASE, 2020, 11 (07)
12345